Last updated on January 2019

Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Ulcerative Colitis | Inflammatory bowel disease | Crohn's Disease
  • Age: - 18 Years
  • Gender: Male or Female

Inclusion Criteria:

  1. Children under the age of 18 years.
  2. IBD Diagnosis
  3. Initiating Vedolizumab therapy

Exclusion Criteria:

  1. Starting Vedolizumab to prevent post operative recurrence

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.